by Boris Jung,
Maxime Fosset, Matthieu Amalric, Elias Baedorf-Kassis, Brian O’Gara, Todd
Sarge, Valerie Moulaire, Vincent Brunot, Arnaud Bourdin, Nicolas Molinari and
Stefan Matecki
Annals of
Intensive Care volume 14, Article number: 91, Published: 18
June 2024
Background
The objective was
to compare sevoflurane, a volatile sedation agent with potential
bronchodilatory properties, with propofol on respiratory mechanics in
critically ill patients with COPD exacerbation.
Methods
Prospective study
in an ICU enrolling critically ill intubated patients with severe COPD
exacerbation and comparing propofol and sevoflurane after 1:1 randomisation.
Respiratory system mechanics (airway resistance, PEEPi, trapped volume,
ventilatory ratio and respiratory system compliance), gas exchange, vitals,
safety and outcome were measured at inclusion and then until H48. Total airway
resistance change from baseline to H48 in both sevoflurane and propofol groups
was the main endpoint.
Results
Sixteen patients
were enrolled and were sedated for 126 h(61–228) in the propofol group and
207 h(171–216) in the sevoflurane group. At baseline, airway resistance
was 21.6cmH2O/l/s(19.8–21.6) in the propofol group and 20.4cmH2O/l/s(18.6–26.4)
in the sevoflurane group, (p = 0.73); trapped volume was 260 ml(176–290) in the propofol group and 73 ml(35–126) in the sevoflurane group, p = 0.02. Intrinsic PEEP was 1.5cmH2O(1–3) in both groups after external PEEP optimization. There was neither
early (H4) or late (H48) significant difference in airway resistance and
respiratory mechanics parameters between the two groups.
Conclusions
In critically ill
patients intubated with COPD exacerbation, there was no significant difference
in respiratory mechanics between sevoflurane and propofol from inclusion to H4
and H48.
No comments:
Post a Comment